CLV Financials: Results, Ratios & Statements | Clover

CLV

Clover

Materials

Clover Corporation is a manufacturer and supplier of functional food ingredients containing long-chain polyunsaturated fatty acids (LCPs) to the healthcare and nutrition markets. The company specializes in microencapsulation technology for omega-3 and omega-6 powders, emulsions, and nutritional oils. Clover's products are used in infant formula and other nutritional applications.

Short position

short percentage0.00%

reported shorts2.5K

shares on issue166.999M

Clover (ASX:CLV) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 2,544 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.73% in November 2021. CLV is classified in the Materials industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

Latest result

Year to 31 Jul 2026 (FY26) vs FY25, figures in AUD, the reporting currency · Company filing, 23 Sep 2026

Revenue: $97.4M (source: Company filing (extracted))vs $86.0M (FY25); Company filing (extracted), as at 6 Oct 2026
NPAT: $10.5M (source: Company filing (extracted))vs $7.0M (FY25); Company filing (extracted), as at 6 Oct 2026
EPS (diluted): $0.063 (source: Company filing (extracted))vs $0.042 (FY25); Company filing (extracted), as at 6 Oct 2026

Rev YoY: +13.3%FY (source: Company filing (extracted))
EPS YoY: +49.0%FY (source: Company filing (extracted))

Company filing (extracted)

Summary of Clover 2026 Annual Report, 23 Sep 2026

Clover Corporation delivered a strong FY2026 with revenue up 13% to $97.4 million and net profit after tax rising 50% to $10.5 million. The Board declared a 1.25 cent dividend. Looking ahead, the company expects first-half FY2027 revenue to be ahead of the prior corresponding period.

Automated summary of the filing; the filing itself is the record.

Key ratios

Year to 31 Jul 2026 (FY); no balance sheet aligned with this period; prices to 9 Oct 2026

Gross margin: n/a
Operating margin: n/a
Net margin: 10.7%
FCF margin: n/a
ROE: n/a
ROA: n/a
FCF conversion: n/a
Net debt (excl. leases): n/a
Net debt / EBITDA: n/a
Current ratio: n/a
Interest cover: n/a
Cash dividends paid / net profit: n/a
Market cap: n/a (no share count we can vouch for)
P/E: 16.0×
P/B: n/a (no share count we can vouch for)

Ratios use the reporting currency (AUD); market cap is in AUD. Source: Company filing (extracted), as at 6 Oct 2026.

Financial statements

Figures in AUD, the reporting currency; Yahoo Finance unless marked

CLV income, newest period first, figures in AUD
Line item	FY26	FY25	FY24	FY23
Revenue	$97.4M (source: Company filing (extracted))	$86.0M	$62.2M	$79.9M
Gross profit	n/a	$26.2M	$16.9M	$23.7M
Operating income	n/a	$8.3M	$2.0M	$8.4M
EBITDA	n/a	$12.2M	$4.0M	$10.0M
EBIT	n/a	$10.7M	$2.8M	$9.1M
Interest expense	n/a	$245.0K	$899.0K	$730.0K
Pretax income	n/a	$10.4M	$1.9M	$8.4M
Tax	n/a	$3.4M	$402.0K	$2.2M
NPAT	$10.5M (source: Company filing (extracted))	$7.0M	$1.5M	$6.2M
Net interest income	n/a	−$245.0K	−$899.0K	−$730.0K
EPS basic	$0.063 (source: Company filing (extracted))	$0.042	$0.009	$0.037
EPS diluted	$0.063 (source: Company filing (extracted))	$0.042	$0.009	$0.037
Shares	n/a	167.0M	167.0M	167.0M

Company filing (extracted)

Financial reports

The company's own filings, newest first

Showing 10 of 14 reports